Live attenuated cholera vaccine with probiotic properties
US11484585B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2018 |
| Grant date | Nov 1, 2022 |
| Priority date | — |
| Expiry date | Jul 12, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are genetically engineered Vibrio cholerae bacterial strains, compositions including the bacterial strains, and methods of using the same for the prevention of Vibrio cholerae infection in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.